Analytic Investors’s VivoSim Labs VIVS Stock Holding History

Analytic Investors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$84K	Buy	+92	New	+$90.1K	﹤0.01%	582

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Analytic Investors's VIVS Position: Q3 2016 in Review

Analytic Investors opened a new position in VivoSim Labs (VIVS) in Q3 2016: 92 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #582 among its holdings.

122 funds tracked by Wall St. Rank hold VIVS as of Q3 2016.

Analytic Investors held 92 shares of VivoSim Labs worth $84K as of Q3 2016.
VivoSim Labs was a new Analytic Investors position in Q3 2016.
VivoSim Labs made up ﹤0.01% of Analytic Investors's portfolio in Q3 2016, its #582 holding.
122 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.